siRNA, Anti-SLC2A3, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT21228WQ-2OMe)

The product SIRGT21228WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC2A3 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC2A3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_006931.2
Alternative Names GLUT3
Related Diseases Huntington Disease, Choriocarcinoma
Purification HPLC
Target Gene
Gene ID 6515
Uniprot ID P11169
Sub Cat Target Species Modification Scale  
SIRGT22228WQ-2F SLC2A3 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT23228WQ-2MOE SLC2A3 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT24228WQ-LNA SLC2A3 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT21228WQ-RB SLC2A3 Human Ribo-modified Inquiry
SIRGT22228WQ-BB SLC2A3 Human Backbone-modified Inquiry

Related Products